Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: A meta-analysis

Journal of Computer Assisted Tomography

Volumn 29, Issue 4, 2005, Pages 438-445

  Bipat, Shandra ^a   Saffire, S K S ^a   Van Delden, Otto M ^a   Bossuyt, Patrick M M ^a   Gouma, Dirk J ^a   Laméris, Johan S ^a   Stoker, Jaap ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Computed tomography; Magnetic resonance imaging; Meta analysis; Pancreatic neoplasm; Ultrasonography

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; MAGNETISM; RANDOM PROCESSES; RESONANCE; ULTRASONOGRAPHY;

BIVARIATE; COMPUTED TOMOGRAPHY; FOLLOW UP; HELICAL COMPUTED TOMOGRAPHIES; META-ANALYSIS; PANCREATIC ADENOCARCINOMA; PANCREATIC NEOPLASM; RANDOM EFFECTS; RESONANCE IMAGING DATA; SENSITIVITY AND SPECIFICITY;

MAGNETIC RESONANCE IMAGING;

ARTICLE; CANCER DIAGNOSIS; CANCER RESECTABILITY; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PARAMETER; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

EID: 23044489174     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000164513.23407.b3     Document Type: Article

References (88)

1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
2. Clarke DL, Thomson SR, Madiba TE, et al. Preoperative imaging of pancreatic cancer: a management-oriented approach. J Am Coll Surg. 2003;196:119-129.
3. Del Frate C, Zanardi R, Mortele K, et al. Advances in imaging for pancreatic disease. Curr Gastroenterol Rep. 2002;4:140-148.
4. Fletcher JG, Wiersema MJ, Farrell MA, et al. Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multidetector row CT. Radiology. 2003;229:81-90.
5. Johnson PT, Heath DG, Hofmann LV, et al. Multidetector-row computed tomography with three-dimensional volume rendering of pancreatic cancer: a complete preoperative staging tool using computed tomography angiography and volume-rendered cholangiopancreatography. J Comput Assist Tomogr. 2003;27:347-353.
6. Pauls S, Sokiranski R, Schwarz M, et al. [Value of spiral CT and MRI (1.5 T) in preoperative diagnosis of tumors of the head of the pancreas]. Rontgenpraxis. 2003;55:3-15.
7. Prokesch RW, Schima W, Chow LC, et al. Multidetector CT of pancreatic adenocarcinoma: diagnostic advances and therapeutic relevance. Eur Radiol. 2003;13:2147-2154.
8. Ishiguchi T, Maruyama K, Fukatsu H, et al. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Semin Surg Oncol. 1998;15: 23-32.
9. Balci NC, Semelka RC. Radiologic diagnosis of pancreatic carcinoma. Eur J Radiol. 2001;38:105-112.
10. Deville WL, Bezemer PD, Bouter LM. Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy. J Clin Epidemiol. 2000;53:65-69.
11. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Radiology. 2003;226:24-28.
12. Berlin JA. Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-Analysis Blinding Study Group. Lancet. 1997;350:185-186.
13. Van Houwelingen HC, Zwinderman KH, Stijnen T. A bivariate approach to meta-analysis. Stat Med. 1993;12:2273-2284.
14. Van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21: 589-624.
15. Diehl SJ, Lehmann KJ, Sadick M, et al. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology. 1998;206:373-378.
16. Keogan MT, McDermott VG, Paulson EK, et al. Pancreatic malignancy: effect of dual-phase helical CT in tumor detection and vascular opacification. Radiology. 1997;205:513-518.
17. Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998;170:1315-1322.
18. Lehmann KJ, Diehl SJ, Lachmann R, et al. [Value of dual-phase-helical CT in the preoperative diagnosis of pancreatic cancer: a prospective study]. Rofo Fortschr Geh Rontgenstr Neuen Bildgeb Verfahr. 1998;168:211-216.
19. Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Public Health. 1993;14:43-68.
20. McNulty NJ, Francis IR, Platt JF, et al. Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology. 2001;220:97-102.
21. Mertz HR, Sechopoulos P, Delbeke D, et al. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc. 2001; 52:367-371.
22. Richter GM, Wunsch C, Schneider B, et al. [Hydro-CT in detection and staging of pancreatic carcinoma]. Radiologe. 1998;38:279-286.
23. Rieber A, Tomczak R, Nussle K, et al. MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT. Br J Radiol. 2000;73:1165-1169.
24. Shoup M, Hodul P, Aranha GV et al. Defining a role for endoscopic ultrasound in staging periampullary tumors. Am J Surg. 2000;179:453-456.
25. Schima W, Fugger R, Schober E, et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am J Roentgenol. 2002; 179:717-724.
26. Imbriaco M, Megibow AJ, Camera L, et al. Dual-phase versus single-phase helical CT to detect and assess resectability of pancreatic carcinoma. AJR Am J Roentgenol. 2002;178:1473-1479.
27. Catalano C, Laghi A, Fraioli F, et al. Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability. Eur Radiol. 2003;13:149-156.
28. Kalady MF, Clary BM, Clark LA, et al. Clinical. utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Ann Surg Oncol. 2002;9:799-806.
29. Laghi A, Iannaccone R, Catalano C, et al. Multislice spiral computed tomography in diagnosis and staging of pancreatic carcinoma: preliminary experience. Dig Liver Dis. 2002;34:732-738.
30. Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology. 1994;192:79-86.
31. Fink C, Grenacher L, Hansmann HJ, et al. [Prospective study to compare high-resolution computed tomography and magnetic resonance imaging in the detection of pancreatic neoplasms: use of intravenous and oral MR contrast media]. Rofo Fortschr Geh Rontgenstr Neuen Bildgeb Verfahr. 2001;173:724-730.
32. Friess H, Langhans J, Ebert M, et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut. 1995;36:771-777.
33. Furukawa T, Tsukamoto Y, Naitoh Y, et al. Differential diagnosis between benign and malignant localized stenosis of the main pancreatic duct by intraductal ultrasound of the pancreas. Am J Gastroenterol. 1994;89: 2038-2041.
34. Inokuma T, Tamaki N, Torizuka T, et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. Radiology. 1995;195:345-352.
35. Nakaizumi A, Uehara H, Iishi H, et al. Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer. Dig Dis Sci. 1995;40:696-700.
36. Palazzo L, Roseau G, Gayet B, et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy. 1993;25:143-150.
37. Pasanen PA, Eskelinen M, Partanen K, et al. A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients. Anticancer Res. 1992;12: 2309-2314.
38. Rodriguez J, Kasberg C, Nipper M, et al. CT-guided needle biopsy of the pancreas: a retrospective analysis of diagnostic accuracy. Am J Gastroenterol. 1992;87:1610-1613.
39. Rosch T, Lorenz R, Braig C, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc. 1991;37:347-352.
40. Snady H, Cooperman A, Siegel J. Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peri-pancreatic mass. Gastrointest Endosc. 1992;38:27-34.
41. Stollfuss JC, Glatting G, Friess H, et al. 2-(fluorine-18)-fluoro-2- deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology. 1995;195:339-344.
42. DelMaschio A, Vanzulli A, Sironi S, et al. Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy. Radiology. 1991;178:95-99.
43. Furukawa T, Oohashi K, Yamao K, et al. Intraductal ultrasonography of the pancreas: development and clinical potential. Endoscopy. 1997;29: 561-569.
44. Muller MF, Meyenberger C, Bertschinger P, et al. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology. 1994; 190:745-751.
45. Vellet AD, Romano W, Bach DB, et al. Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T. Radiology. 1992;183:87-95.
46. Papas M, Takacs T, Tron L, et al. The possible role of F-18 FDG positron emission tomography in the differential diagnosis of focal pancreatic lesions. Clin Nucl Med. 2002;27:197-201.
47. Adamek HE, Albert J, Breer H, et al. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet. 2000; 356:190-193.
48. Diehl SJ, Lehmann KJ, Gaa J, et al. [The value of magnetic resonance tomography (MRT), magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of pancreatic tumors]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 1999;170:463-469.
49. Dobritz M, Fellner FA, Baum U, et al. [MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2002;174:893-897.
50. Hochwald SN, Rofsky NM, Dobryansky M, et al. Magnetic resonance imaging with magnetic resonance cholangiopancreatography accurately predicts resectability of pancreatic carcinoma. J Gastrointest Surg. 1999; 3:506-511.
51. Richter A, Gaa J, Niedergethmann M, et al. [Ultrafast magnetic resonance tomography changes the standard in pancreas diagnosis]. Chirurg. 2001; 72:697-703.
52. Becker D, Strobel D, Bernatik T, et al. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc. 2001;53:784-789.
53. Karlson BM, Ekbom A, Lindgren PG, et al. Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology. 1999;213: 107-111.
54. Maringhini A, Ciambra M, Raimondo M, et al. Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer. Pancreas. 1993;8: 146-150.
55. Rickes S, Unkrodt K, Neye H, et al. Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol. 2002;37:1313-1320.
56. Andren-Sandberg A, Lindberg CG, Lundstedt C, et al. Computed tomography and laparoscopy in the assessment of the patient with pancreatic cancer. J Am Coll Surg. 1998;186:35-40.
57. Bluemke DA, Cameron JL, Hruban RH, et al. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology. 1995;197:381-385.
58. Bottger T, Engelman R, Seifert JK, et al. Preoperative diagnostics in pancreatic carcinoma: would less be better? Langenbecks Arch Surg. 1998; 383:243-248.
59. Hommeyer SC, Freeny PC, Crabo LG. Carcinoma of the head of the pancreas: evaluation of the pancreaticoduodenal veins with dynamic CT-potential for improved accuracy in staging. Radiology. 1995;196:233-238.
60. Hough TJ, Raptopoulos V, Siewert B, et al. Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas. AJR Am J Roentgenol. 1999;173:1509-1512.
61. Howard TJ, Chin AC, Streib EW, et al. Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg. 1997;174: 237-241.
62. Lentschig MG, Reimer P, Rummeny E, et al. [The value of 3-phase spiral CT and magnetic resonance tomography in preoperative diagnosis of pancreatic carcinoma]. Radiologe. 1996;36:406-412.
63. Lu DS, Reber HA, Krasny RM, et al. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol. 1997;168:1439-1443.
64. Phoa SS, Reeders JW, Rauws EA, et al. Spiral computed tomography forpreoperative staging of potentially resectable carcinoma of the pancreatic head. Br J Surg. 1999;86:789-794.
65. Raptopoulos V, Steer ML, Sheiman RG, et al. The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery. AJR Am J Roentgenol. 1997;168: 971-977.
66. Valls C, Andia E, Sanchez A, et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol. 2001;178:821-826.
67. Zeman RK, Cooper C, Zeiberg AS, et al. TNM staging of pancreatic carcinoma using helical CT. AJR Am J Roentgenol. 1997;169:459-464.
68. Procacci C, Biasiutti C, Carbognin G, et al. Spiral computed tomography assessment of resectability of pancreatic ductal adenocarcinoma: analysis of results. Dig Liver Dis. 2002;34:739-747.
69. Minniti S, Bruno C, Biasiutti C, et al. Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma. J Clin Ultrasound. 2003;31:175-182.
70. Awad SS, Colletti L, Mulholland M, et al. Multimodality staging optimizes resectability in patients with pancreatic and ampullary cancer. Am Surg. 1997;63:634-638.
71. Bakkevold KE, Arnesjo B, Kambestad B. Carcinoma of the pancreas and papilla of Vater-assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients. Eur J Surg Oncol. 1992; 18:494-507.
72. Freeny PC, Traverso LW, Ryan JA. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg. 1993; 165:600-606.
73. Gress FG, Hawes RH, Savides TJ, et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc. 1999;50:786-791.
74. Loyer EM, David CL, Dubrow RA, et al. Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. Abdom Imaging. 1996;21:202-206.
75. McCarthy MJ, Evans J, Sagar G, et al. Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg. 1998;85:320-325.
76. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability-report of the Radiology Diagnostic Oncology Group. Radiology. 1995;195:327-332.
77. O'Malley ME, Boland GW, Wood BJ, et al. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol. 1999;173:1513-1518.
78. Warshaw AL, Gu ZY, Wittenberg J, et al. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg. 1990;125:230-233.
79. Zeiss J, Coombs RJ, Bielke D. CT presentation and staging accuracy of pancreatic adenocarcinoma. Int J Pancreatol. 1990;7:49-53.
80. Ahmad NA, Lewis JD, Siegelman ES, et al. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma. Am J Gastroenterol. 2000;95:1926-1931.
81. McFarland EG, Kaufman JA, Saini S, et al. Preoperative staging of cancer of the pancreas: value of MR angiography versus conventional angiography in detecting portal venous invasion. AJR Am J Roentgenol. 1996; 166:37-43.
82. Angeli E, Venturini M, Vanzulli A, et al. Color Doppler imaging in the assessment of vascular involvement by pancreatic carcinoma. AJR Am J Roentgenol. 1997;168:193-197.
83. Ishida H, Konno K, Hamashima Y, et al. Assessment of resectability of pancreatic carcinoma by color Doppler sonography. Abdom Imaging. 1999;24:295-298.
84. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061-1066.
85. Rutter CM, Gatsonis CA. Regression methods for meta-analysis of diagnostic test data. Acad Radiol. 1995;(Suppl 1):S48-S56.
86. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20:2865-2884.
87. Jadvar H, Fischman AJ. Evaluation of pancreatic carcinoma with FDG PET. Abdom Imaging. 2001;26:254-259.
88. Keogan MT, Tyler D, Clark L, et al. Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol. 1998;171:1565-1570.